Neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced parkinsonism in mice

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief. It has been highlighted that there is image manipulation. Fig. 6 b), e) ad f) are the same images from Fig 5 a), b), c) from Patil, S.P., Jain, P.D., Ghumatkar, P.J., Tambe, R., Sathaye, S., 2014. Neuroprotective effect of metformin in MPTP-induced Parkinson’s disease in mice. Neuroscience 277, 747–754 and used to describe different drug doses and treatments in the paper. Fig. 8 d), e) and f) are the same image manipulated to be results for different drug treatments. Fig. 10a), b) and h) are the same images as Fig. 7 B) in the paper Patil, S.P., Jain, P.D., Ghumatkar, P.J., Tambe, R., Sathaye, S., 2014. Neuroprotective effect of metformin in MPTP-induced Parkinson’s disease in mice. Neuroscience 277, 747–754 and used to describe different drug treatments. The authors acknowledge there are serious errors and agree with the retraction of this paper.